Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2026
Correlations Between Pregnancy-Associated Plasma Protein A Levels and Pregnancy Characteristics, Placental Volume, Vascularization, and Histopathology.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dankó István, Tankó András, Kelemen Edit, Temesváry Béla, Cserni Gábor
Аннотация
OBJECTIVE: To evaluate the associations between pregnancy-associated plasma protein A (PAPP-A) levels and pregnancy-associated conditions, perinatal outcomes, and placental histopathology.
METHODS: This retrospective, single-center cohort analysis included cases of preterm and term deliveries from pregnancies complicated by preeclampsia and fetal growth restriction or gestational hypertension. A correlation analysis was performed to assess the relationship between PAPP-A levels and neonatal parameters, the prevalence of various pregnancy complications, and placental and birth weight percentiles and ratios. Associations between placental histopathological entities and PAPP-A were explored in different subgroups defined by PAPP-A multiple of the median (MoM) ranges. Potential associations between PAPP-A levels and placental capillarization were also investigated.
RESULTS: A total of 74 pregnancies were investigated. PAPP-A levels were significantly lower in cases involving cesarean section (P = 0.002), preterm birth (P = 0.030), and/or preeclampsia (P = 0.002). Among the preeclamptic cases, early-onset preeclampsia was associated with a significantly lower PAPP-A level (P < 0.001). No significant associations were identified between first-trimester PAPP-A levels and placental weight percentile, birth weight percentile, villous capillarization, or the percentage of intact terminal villi; however, correlations were found between low PAPP-A levels and placental weight-to-birth weight ratios of < 1:8 (Kruskal-Wallis test P = 0.004; Spearman's correlation P = 0.011). PAPP-A levels were also significantly lower in the presence of distal villous hypoplasia (P < 0.001), accelerated villous maturation (P < 0.001), or avascular villi (P < 0.001) in the placenta.
CONCLUSION: Lower PAPP-A levels may represent an early marker of pathological placentation in the background of preeclampsia and fetal growth restriction-especially in early-onset cases-which are characterized by villous underdevelopment and a non-branching villous tree pattern on placental histopathology. From a clinical translation perspective, PAPP-A levels may serve as a potential early indicator of pregnancies that warrant close monitoring during clinical management.
METHODS: This retrospective, single-center cohort analysis included cases of preterm and term deliveries from pregnancies complicated by preeclampsia and fetal growth restriction or gestational hypertension. A correlation analysis was performed to assess the relationship between PAPP-A levels and neonatal parameters, the prevalence of various pregnancy complications, and placental and birth weight percentiles and ratios. Associations between placental histopathological entities and PAPP-A were explored in different subgroups defined by PAPP-A multiple of the median (MoM) ranges. Potential associations between PAPP-A levels and placental capillarization were also investigated.
RESULTS: A total of 74 pregnancies were investigated. PAPP-A levels were significantly lower in cases involving cesarean section (P = 0.002), preterm birth (P = 0.030), and/or preeclampsia (P = 0.002). Among the preeclamptic cases, early-onset preeclampsia was associated with a significantly lower PAPP-A level (P < 0.001). No significant associations were identified between first-trimester PAPP-A levels and placental weight percentile, birth weight percentile, villous capillarization, or the percentage of intact terminal villi; however, correlations were found between low PAPP-A levels and placental weight-to-birth weight ratios of < 1:8 (Kruskal-Wallis test P = 0.004; Spearman's correlation P = 0.011). PAPP-A levels were also significantly lower in the presence of distal villous hypoplasia (P < 0.001), accelerated villous maturation (P < 0.001), or avascular villi (P < 0.001) in the placenta.
CONCLUSION: Lower PAPP-A levels may represent an early marker of pathological placentation in the background of preeclampsia and fetal growth restriction-especially in early-onset cases-which are characterized by villous underdevelopment and a non-branching villous tree pattern on placental histopathology. From a clinical translation perspective, PAPP-A levels may serve as a potential early indicator of pregnancies that warrant close monitoring during clinical management.